Antagonists in poor-responder patients

This publication has 31 references indexed in Scilit:

• Differentiating clinical profiles: predicting good responders, poor responders, and hyperresponders
  Fertility and Sterility, 2001
• Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques
  Fertility and Sterility, 2000
• Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome
  Fertility and Sterility, 1997
• Endocrinology: Ovarian reserve test with the gonadotrophin-releasing hormone agonist buserelin: correlation with in-vitro fertilization outcome
  Human Reproduction, 1996
• The poor-responder patient in an in vitro fertilization-embryo transfer (IVF-ET) program
  Gynecological Endocrinology, 1994
• The prognostic importance of the number of oocytes retrieved and estradiol levels in poor and normal responders in in vitro fertilization (IVF) treatment
  Journal of Assisted Reproduction and Genetics, 1992
• Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulated follicle-stimulating hormone levels
  Fertility and Sterility, 1992
• Comparison of ‘poor’ responders with ‘good’ responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization
  Human Reproduction, 1991
• Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age
  Fertility and Sterility, 1991
• High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilization
  Journal of Assisted Reproduction and Genetics, 1989